Showing results (191-200 of 589) with videos related to
Sort By:
Pageof 59
Lancet (London, England)|January 11, 1986
Non-steroidal anti-inflammatory drugs and renal failureD H Adams, A J Howie, J Michael, et al.Clinical Science (London, England : 1979)|May 1, 1983
Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patientsD R Blake, A Blann, P A Bacon, et al.The Quarterly Journal of Medicine|January 1, 1982
Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 casesD G Scott, P A Bacon, P J Elliott, et al.Journal of Clinical Pathology|February 1, 1990
Rheumatoid lymphadenopathy: a morphological and immunohistochemical studyG M Kondratowicz, D P Symmons, P A Bacon, et al.Clinical Rheumatology|September 1, 1988
Treatment of psoriatic arthritis with sulphasalazine: a one year open studyM Farr, G D Kitas, L Waterhouse, et al.BMJ (Clinical Research Ed.)|December 5, 1992
Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritisP Emery, M Salmon, H Bradley, et al.British Journal of Rheumatology|February 1, 1990
Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled studyM Farr, G D Kitas, L Waterhouse, et al.The Journal of Rheumatology|August 1, 1997
Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosusT Stoll, C Gordon, B Seifert, et al.Arthritis and Rheumatism|January 27, 1999
Localized bowel vasculitis: postoperative cyclophosphamide or not?K Raza, A R Exley, D M Carruthers, et al.Clinical and Experimental Immunology|June 1, 1992
MHC restriction of synovial fluid lymphocyte responses to the triggering organism in reactive arthritis. Absence of a class I-restricted responseA B Hassell, D Pilling, D Reynolds, et al.Pageof 59